- Filed
- Mar 23, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Mar 18, 2021 | 31.11M sh |
| Stock Repurchased | Q3 2021 · Jan 31, 2021 | $45.31K |
| Stock Repurchased | Q3 2021 · Jan 31, 2020 | $22.39K |
| Cash And Equivalents | Q3 2021 · Jan 31, 2021 | $0 |
| Cash And Equivalents | Q3 2021 · Apr 30, 2020 | $49.19K |
| Cash And Equivalents restated | Q3 2021 · Jan 31, 2020 | $242.19K |
| Cash And Equivalents restated | Q3 2021 · Apr 30, 2019 | $251.45K |
| Current Liabilities | Q3 2021 · Jan 31, 2021 | $1.97M |
| Current Liabilities | Q3 2021 · Apr 30, 2020 | $2.13M |
| Total Liabilities | Q3 2021 · Jan 31, 2021 | $2.12M |
| Total Liabilities | Q3 2021 · Apr 30, 2020 | $2.4M |
| Current Assets | Q3 2021 · Jan 31, 2021 | $235.72K |
| Current Assets | Q3 2021 · Apr 30, 2020 | $296.75K |
| Total Assets | Q3 2021 · Jan 31, 2021 | $3.44M |
| Total Assets | Q3 2021 · Apr 30, 2020 | $3.61M |
| Capex | Q3 2021 · Jan 31, 2020 | $170.03K |
| Operating Cash Flow restated | Q3 2021 · Jan 31, 2020 | −$1.5M |
| Sga Expense restated | Q3 2021 · Jan 31, 2020 | $1.76M |
| Sga Expense restated | Q3 2021 · Jan 31, 2020 | $2.58M |
| Net Income restated | Q3 2021 · Jan 31, 2020 | −$2.18M |
| Net Income restated | Q3 2021 · Jan 31, 2020 | −$3.09M |
| Operating Income restated | Q3 2021 · Jan 31, 2020 | −$2.18M |
| Operating Income restated | Q3 2021 · Jan 31, 2020 | −$3.06M |
| Gross Profit | Q3 2021 · Jan 31, 2020 | −$231.84K |
| Gross Profit | Q3 2021 · Jan 31, 2020 | −$23.64K |
| Revenue | Q3 2021 · Jan 31, 2020 | $119.45K |
| Revenue | Q3 2021 · Jan 31, 2020 | $845.05K |